Rank | Gene Set | Z-score |
---|---|---|
1 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 6.24331769 |
2 | intestinal absorption (GO:0050892) | 5.41866205 |
3 | intestinal cholesterol absorption (GO:0030299) | 5.15886730 |
4 | surfactant homeostasis (GO:0043129) | 4.97479501 |
5 | angiotensin maturation (GO:0002003) | 4.96134952 |
6 | desmosome organization (GO:0002934) | 4.64748962 |
7 | hemidesmosome assembly (GO:0031581) | 4.52130422 |
8 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.20545973 |
9 | chemical homeostasis within a tissue (GO:0048875) | 4.15474616 |
10 | cell communication involved in cardiac conduction (GO:0086065) | 3.99927239 |
11 | virion attachment to host cell (GO:0019062) | 3.94370192 |
12 | adhesion of symbiont to host cell (GO:0044650) | 3.94370192 |
13 | epoxygenase P450 pathway (GO:0019373) | 3.93882212 |
14 | flavonoid metabolic process (GO:0009812) | 3.83606984 |
15 | axonemal dynein complex assembly (GO:0070286) | 3.78691243 |
16 | primary alcohol catabolic process (GO:0034310) | 3.76627068 |
17 | vitamin transmembrane transport (GO:0035461) | 3.68987073 |
18 | drug catabolic process (GO:0042737) | 3.68081987 |
19 | regulation of water loss via skin (GO:0033561) | 3.66095211 |
20 | vitamin A metabolic process (GO:0006776) | 3.55244550 |
21 | regulation of bile acid biosynthetic process (GO:0070857) | 3.55150580 |
22 | hormone catabolic process (GO:0042447) | 3.54831993 |
23 | actin filament depolymerization (GO:0030042) | 3.43741651 |
24 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.43308849 |
25 | intestinal epithelial cell development (GO:0060576) | 3.42832345 |
26 | regulation of cholesterol homeostasis (GO:2000188) | 3.41726436 |
27 | water homeostasis (GO:0030104) | 3.41615486 |
28 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.41481219 |
29 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.39298755 |
30 | fructose metabolic process (GO:0006000) | 3.36637331 |
31 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.34284072 |
32 | cellular glucuronidation (GO:0052695) | 3.28132913 |
33 | sulfate transmembrane transport (GO:1902358) | 3.26165959 |
34 | urea cycle (GO:0000050) | 3.25173664 |
35 | establishment of skin barrier (GO:0061436) | 3.22599373 |
36 | sarcomere organization (GO:0045214) | 3.19054035 |
37 | adhesion of symbiont to host (GO:0044406) | 3.18334131 |
38 | urea metabolic process (GO:0019627) | 3.16347856 |
39 | cardiac conduction (GO:0061337) | 3.16223988 |
40 | epithelial cell-cell adhesion (GO:0090136) | 3.14265452 |
41 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.13612770 |
42 | regulation of guanylate cyclase activity (GO:0031282) | 3.12739728 |
43 | renal system process involved in regulation of blood volume (GO:0001977) | 3.10571035 |
44 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.10430603 |
45 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.09937458 |
46 | regulation of cholesterol metabolic process (GO:0090181) | 3.08738267 |
47 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.08525953 |
48 | uronic acid metabolic process (GO:0006063) | 3.08266062 |
49 | glucuronate metabolic process (GO:0019585) | 3.08266062 |
50 | bile acid and bile salt transport (GO:0015721) | 3.08158808 |
51 | digestive system process (GO:0022600) | 3.03266565 |
52 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 3.02527771 |
53 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.97587229 |
54 | bicarbonate transport (GO:0015701) | 2.97533186 |
55 | epithelial structure maintenance (GO:0010669) | 2.96696897 |
56 | sodium ion export (GO:0071436) | 2.96503078 |
57 | glomerular filtration (GO:0003094) | 2.95694255 |
58 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.95563741 |
59 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.95174318 |
60 | motile cilium assembly (GO:0044458) | 2.95004176 |
61 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.94297637 |
62 | regulation of p38MAPK cascade (GO:1900744) | 2.93151260 |
63 | membrane repolarization during action potential (GO:0086011) | 2.92251462 |
64 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.90436688 |
65 | renal filtration (GO:0097205) | 2.90008526 |
66 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.89013592 |
67 | nitrogen cycle metabolic process (GO:0071941) | 2.86101055 |
68 | lung epithelium development (GO:0060428) | 2.84147779 |
69 | auditory receptor cell differentiation (GO:0042491) | 2.83968132 |
70 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.83689460 |
71 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.83655700 |
72 | relaxation of cardiac muscle (GO:0055119) | 2.83178086 |
73 | regulation of cardioblast differentiation (GO:0051890) | 2.83114430 |
74 | exogenous drug catabolic process (GO:0042738) | 2.81787801 |
75 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.80701956 |
76 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 2.79885450 |
77 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 2.79885450 |
78 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.79093001 |
79 | regulation of triglyceride catabolic process (GO:0010896) | 2.75197584 |
80 | activation of Rac GTPase activity (GO:0032863) | 2.73295735 |
81 | positive regulation of p38MAPK cascade (GO:1900745) | 2.73039123 |
82 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.72993802 |
83 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.72526186 |
84 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.72526186 |
85 | endocrine process (GO:0050886) | 2.72526186 |
86 | transcytosis (GO:0045056) | 2.72105286 |
87 | positive regulation of lipid catabolic process (GO:0050996) | 2.71523205 |
88 | O-glycan processing (GO:0016266) | 2.71078654 |
89 | peptide catabolic process (GO:0043171) | 2.70756375 |
90 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.67096427 |
91 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.65164395 |
92 | regulation of pseudopodium assembly (GO:0031272) | 2.62903710 |
93 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 2.62596999 |
94 | cardiac muscle cell action potential (GO:0086001) | 2.57884570 |
95 | regulation of systemic arterial blood pressure (GO:0003073) | 2.57653586 |
96 | sperm capacitation (GO:0048240) | 2.57419649 |
97 | positive regulation of pseudopodium assembly (GO:0031274) | 2.56700360 |
98 | cell communication by electrical coupling (GO:0010644) | 2.56047898 |
99 | positive regulation of fatty acid oxidation (GO:0046321) | 2.55894355 |
100 | myelin maintenance (GO:0043217) | 2.55097339 |
101 | regulation of glucose import in response to insulin stimulus (GO:2001273) | 2.54370900 |
102 | negative regulation of myotube differentiation (GO:0010832) | 2.51589136 |
103 | positive regulation of respiratory burst (GO:0060267) | 2.51381789 |
104 | ethanol metabolic process (GO:0006067) | 2.51366396 |
105 | amino-acid betaine transport (GO:0015838) | 2.51141452 |
106 | carnitine transport (GO:0015879) | 2.51141452 |
107 | phosphate ion transmembrane transport (GO:0035435) | 2.49994890 |
108 | macroautophagy (GO:0016236) | 2.49359835 |
109 | receptor recycling (GO:0001881) | 2.49196583 |
110 | gap junction assembly (GO:0016264) | 2.49107335 |
111 | phospholipid homeostasis (GO:0055091) | 2.48185702 |
112 | regulation of viral release from host cell (GO:1902186) | 2.47034937 |
113 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.46875265 |
114 | NADH metabolic process (GO:0006734) | 2.46231433 |
115 | cellular potassium ion homeostasis (GO:0030007) | 2.45971510 |
116 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.45303192 |
117 | carnitine transmembrane transport (GO:1902603) | 2.45149143 |
118 | sulfate transport (GO:0008272) | 2.44604589 |
119 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.44373303 |
120 | cholesterol homeostasis (GO:0042632) | 2.43062750 |
121 | establishment of apical/basal cell polarity (GO:0035089) | 2.43015129 |
122 | phospholipid efflux (GO:0033700) | 2.42726941 |
123 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.42002867 |
124 | tight junction assembly (GO:0070830) | 2.41748594 |
125 | sterol homeostasis (GO:0055092) | 2.41581491 |
126 | diacylglycerol metabolic process (GO:0046339) | 2.40519689 |
127 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.40358791 |
128 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 2.40086104 |
129 | carnitine shuttle (GO:0006853) | 2.39605924 |
130 | primary alcohol metabolic process (GO:0034308) | 2.39481573 |
131 | sodium ion homeostasis (GO:0055078) | 2.38529541 |
132 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.37717350 |
133 | sulfur amino acid catabolic process (GO:0000098) | 2.37665944 |
134 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.36500328 |
135 | multicellular organismal water homeostasis (GO:0050891) | 2.36430342 |
136 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.36365602 |
137 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.36365602 |
138 | response to food (GO:0032094) | 2.36234184 |
139 | glutathione biosynthetic process (GO:0006750) | 2.36182944 |
140 | regulation of actin filament-based movement (GO:1903115) | 2.35900788 |
141 | glucose 6-phosphate metabolic process (GO:0051156) | 2.35169153 |
142 | cell-cell junction maintenance (GO:0045217) | 2.34683639 |
143 | neurotransmitter biosynthetic process (GO:0042136) | 2.34217168 |
144 | potassium ion import (GO:0010107) | 2.33616304 |
145 | phenylpropanoid metabolic process (GO:0009698) | 2.32327664 |
146 | lipoprotein metabolic process (GO:0042157) | 2.31032583 |
147 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.29886841 |
148 | cellular sodium ion homeostasis (GO:0006883) | 2.28618678 |
149 | regulation of skeletal muscle contraction (GO:0014819) | 2.27838791 |
150 | cardiac muscle contraction (GO:0060048) | 2.25133295 |
151 | tricarboxylic acid cycle (GO:0006099) | 2.24766548 |
152 | fatty acid transmembrane transport (GO:1902001) | 2.24660869 |
153 | drug metabolic process (GO:0017144) | 2.24323378 |
154 | membrane repolarization (GO:0086009) | 2.23550743 |
155 | plasma membrane repair (GO:0001778) | 2.23479826 |
156 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.23455911 |
157 | transepithelial transport (GO:0070633) | 2.23355193 |
158 | * actomyosin structure organization (GO:0031032) | 2.22394894 |
159 | renal absorption (GO:0070293) | 2.21322348 |
160 | cholesterol efflux (GO:0033344) | 2.21162711 |
161 | protein localization to endosome (GO:0036010) | 2.20757584 |
162 | ethanol oxidation (GO:0006069) | 2.20697686 |
163 | intermediate filament organization (GO:0045109) | 2.19088784 |
164 | sulfur compound transport (GO:0072348) | 2.18729764 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 5.10528492 |
2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 3.03458961 |
3 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.95555658 |
4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.67327786 |
5 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.48402627 |
6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.45425518 |
7 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.42689414 |
8 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.24162960 |
9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.11689499 |
10 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.10239926 |
11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06776620 |
12 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 2.05229371 |
13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.05092789 |
14 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.00093379 |
15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95734395 |
16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.94866804 |
17 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.85047521 |
18 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.81872122 |
19 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.80434740 |
20 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.78981560 |
21 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72319719 |
22 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.69202921 |
23 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.66005589 |
24 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.63571185 |
25 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.60000272 |
26 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.59852126 |
27 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56750179 |
28 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54523624 |
29 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.53509983 |
30 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.51451242 |
31 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.49631793 |
32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.48220798 |
33 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46551616 |
34 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.40521962 |
35 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.40169865 |
36 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39914215 |
37 | * DROSHA_22980978_ChIP-Seq_HELA_Human | 1.37408224 |
38 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36364699 |
39 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.36094220 |
40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.36017001 |
41 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.33960085 |
42 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.33858635 |
43 | P68_20966046_ChIP-Seq_HELA_Human | 1.30148349 |
44 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.29559378 |
45 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.29559378 |
46 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.28434922 |
47 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.27772501 |
48 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.27506622 |
49 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26746637 |
50 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.25079463 |
51 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.24985057 |
52 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23904571 |
53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23076856 |
54 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21981486 |
55 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.21308520 |
56 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.21016417 |
57 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19917519 |
58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18936055 |
59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.18071013 |
60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.16952748 |
61 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.16330236 |
62 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16122449 |
63 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.15447864 |
64 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14107297 |
65 | * NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13186624 |
66 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.13136600 |
67 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.12776806 |
68 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12745302 |
69 | KDM2B_26808549_Chip-Seq_K562_Human | 1.12048161 |
70 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11627674 |
71 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.10342529 |
72 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.09379546 |
73 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.08234251 |
74 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.08123758 |
75 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.07415113 |
76 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07120476 |
77 | * THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.06957015 |
78 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.06762152 |
79 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.06708864 |
80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06149543 |
81 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.03912820 |
82 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03873171 |
83 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.03193935 |
84 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02653773 |
85 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.02541925 |
86 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.01941723 |
87 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01349249 |
88 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.01117206 |
89 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.00551290 |
90 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99040165 |
91 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.99028326 |
92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.98578817 |
93 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.98541430 |
94 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 0.97584476 |
95 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97520920 |
96 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.97397982 |
97 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.97352755 |
98 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.97007943 |
99 | SA1_27219007_Chip-Seq_Bcells_Human | 0.96154884 |
100 | GATA1_19941826_ChIP-Seq_K562_Human | 0.95626538 |
101 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.95552506 |
102 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.93825341 |
103 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.93563574 |
104 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.93520433 |
105 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.93422034 |
106 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.92656827 |
107 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.92444047 |
108 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.92444047 |
109 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91811330 |
110 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.91803623 |
111 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91760862 |
112 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.91757257 |
113 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.91465625 |
114 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.91180074 |
115 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.90755757 |
116 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.90578428 |
117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.90486361 |
118 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90379955 |
119 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90379955 |
120 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.90362761 |
121 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.90260623 |
122 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90184551 |
123 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.89903107 |
124 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89839912 |
125 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.89783755 |
126 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.89231849 |
127 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.89109611 |
128 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.88789613 |
129 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.87467049 |
130 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.86660297 |
131 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.85999387 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0010234_abnormal_vibrissa_follicle | 5.71223777 |
2 | MP0005360_urolithiasis | 4.64095352 |
3 | MP0001666_abnormal_nutrient_absorption | 3.75819966 |
4 | MP0004264_abnormal_extraembryonic_tissu | 2.96243297 |
5 | MP0005085_abnormal_gallbladder_physiolo | 2.81224593 |
6 | MP0002139_abnormal_hepatobiliary_system | 2.76350750 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.75300661 |
8 | MP0004782_abnormal_surfactant_physiolog | 2.72043580 |
9 | MP0003705_abnormal_hypodermis_morpholog | 2.38046389 |
10 | MP0005409_darkened_coat_color | 2.36959814 |
11 | MP0000462_abnormal_digestive_system | 2.34404936 |
12 | MP0002796_impaired_skin_barrier | 2.34063394 |
13 | MP0005167_abnormal_blood-brain_barrier | 2.24079731 |
14 | MP0009840_abnormal_foam_cell | 2.22809904 |
15 | MP0000537_abnormal_urethra_morphology | 2.17770539 |
16 | MP0005451_abnormal_body_composition | 2.17053074 |
17 | MP0003252_abnormal_bile_duct | 2.12835808 |
18 | MP0002837_dystrophic_cardiac_calcinosis | 2.10751173 |
19 | MP0002822_catalepsy | 2.05737178 |
20 | MP0003866_abnormal_defecation | 2.04897837 |
21 | MP0009379_abnormal_foot_pigmentation | 1.99542079 |
22 | MP0005670_abnormal_white_adipose | 1.99391964 |
23 | MP0000678_abnormal_parathyroid_gland | 1.92119917 |
24 | MP0005365_abnormal_bile_salt | 1.89177301 |
25 | MP0010329_abnormal_lipoprotein_level | 1.82844048 |
26 | MP0000751_myopathy | 1.80264776 |
27 | MP0008004_abnormal_stomach_pH | 1.74842459 |
28 | MP0003191_abnormal_cellular_cholesterol | 1.74616442 |
29 | MP0004084_abnormal_cardiac_muscle | 1.74549234 |
30 | MP0002249_abnormal_larynx_morphology | 1.73389999 |
31 | MP0004043_abnormal_pH_regulation | 1.71073793 |
32 | MP0010678_abnormal_skin_adnexa | 1.68812535 |
33 | MP0005083_abnormal_biliary_tract | 1.67814829 |
34 | MP0003283_abnormal_digestive_organ | 1.67037640 |
35 | MP0003878_abnormal_ear_physiology | 1.64475680 |
36 | MP0005377_hearing/vestibular/ear_phenot | 1.64475680 |
37 | MP0005076_abnormal_cell_differentiation | 1.60593179 |
38 | MP0001664_abnormal_digestion | 1.58972546 |
39 | MP0003879_abnormal_hair_cell | 1.56098355 |
40 | MP0001849_ear_inflammation | 1.50961629 |
41 | MP0003300_gastrointestinal_ulcer | 1.50736209 |
42 | MP0004215_abnormal_myocardial_fiber | 1.45488038 |
43 | MP0001958_emphysema | 1.45257915 |
44 | MP0000579_abnormal_nail_morphology | 1.42373472 |
45 | MP0002098_abnormal_vibrissa_morphology | 1.41432842 |
46 | MP0002138_abnormal_hepatobiliary_system | 1.40447574 |
47 | MP0002234_abnormal_pharynx_morphology | 1.35656811 |
48 | MP0004036_abnormal_muscle_relaxation | 1.33297549 |
49 | MP0005381_digestive/alimentary_phenotyp | 1.32111839 |
50 | MP0009780_abnormal_chondrocyte_physiolo | 1.31509170 |
51 | MP0006138_congestive_heart_failure | 1.26337111 |
52 | MP0002909_abnormal_adrenal_gland | 1.25173888 |
53 | MP0001663_abnormal_digestive_system | 1.24592525 |
54 | MP0003566_abnormal_cell_adhesion | 1.21839857 |
55 | MP0001765_abnormal_ion_homeostasis | 1.21126908 |
56 | MP0005501_abnormal_skin_physiology | 1.21047315 |
57 | MP0004019_abnormal_vitamin_homeostasis | 1.17536117 |
58 | MP0010352_gastrointestinal_tract_polyps | 1.17284149 |
59 | MP0000467_abnormal_esophagus_morphology | 1.16721780 |
60 | MP0003646_muscle_fatigue | 1.16475602 |
61 | MP0005330_cardiomyopathy | 1.15519246 |
62 | MP0004484_altered_response_of | 1.15514488 |
63 | MP0003868_abnormal_feces_composition | 1.15130162 |
64 | MP0009643_abnormal_urine_homeostasis | 1.15116232 |
65 | MP0000377_abnormal_hair_follicle | 1.15049825 |
66 | MP0004270_analgesia | 1.13937708 |
67 | MP0002254_reproductive_system_inflammat | 1.12293836 |
68 | MP0003453_abnormal_keratinocyte_physiol | 1.12246821 |
69 | MP0000538_abnormal_urinary_bladder | 1.11886548 |
70 | MP0002118_abnormal_lipid_homeostasis | 1.10635313 |
71 | MP0003183_abnormal_peptide_metabolism | 1.10281522 |
72 | MP0010155_abnormal_intestine_physiology | 1.10207270 |
73 | MP0002972_abnormal_cardiac_muscle | 1.05822165 |
74 | MP0005375_adipose_tissue_phenotype | 1.05771904 |
75 | MP0003045_fibrosis | 1.05074873 |
76 | MP0005275_abnormal_skin_tensile | 1.04874493 |
77 | MP0004185_abnormal_adipocyte_glucose | 1.04506103 |
78 | MP0010368_abnormal_lymphatic_system | 1.03874794 |
79 | MP0000477_abnormal_intestine_morphology | 1.03655959 |
80 | MP0002876_abnormal_thyroid_physiology | 1.03392711 |
81 | MP0000566_synostosis | 1.01532414 |
82 | MP0004087_abnormal_muscle_fiber | 0.99391546 |
83 | MP0002896_abnormal_bone_mineralization | 0.96389019 |
84 | MP0010771_integument_phenotype | 0.94394489 |
85 | MP0003806_abnormal_nucleotide_metabolis | 0.93701551 |
86 | MP0000749_muscle_degeneration | 0.93573647 |
87 | MP0000747_muscle_weakness | 0.93462316 |
88 | MP0002971_abnormal_brown_adipose | 0.92132512 |
89 | MP0005636_abnormal_mineral_homeostasis | 0.91727598 |
90 | MP0001544_abnormal_cardiovascular_syste | 0.91458346 |
91 | MP0005385_cardiovascular_system_phenoty | 0.91458346 |
92 | MP0004130_abnormal_muscle_cell | 0.90512891 |
93 | MP0006054_spinal_hemorrhage | 0.90439424 |
94 | MP0004858_abnormal_nervous_system | 0.89750919 |
95 | MP0005166_decreased_susceptibility_to | 0.89595072 |
96 | MP0003329_amyloid_beta_deposits | 0.86653463 |
97 | MP0000003_abnormal_adipose_tissue | 0.85676384 |
98 | MP0003950_abnormal_plasma_membrane | 0.84208567 |
99 | MP0000383_abnormal_hair_follicle | 0.83223981 |
100 | MP0001873_stomach_inflammation | 0.82329448 |
101 | MP0005332_abnormal_amino_acid | 0.81564828 |
102 | MP0003123_paternal_imprinting | 0.80983703 |
103 | MP0005620_abnormal_muscle_contractility | 0.80680390 |
104 | MP0001216_abnormal_epidermal_layer | 0.80567136 |
105 | MP0004147_increased_porphyrin_level | 0.78650039 |
106 | MP0003137_abnormal_impulse_conducting | 0.78391909 |
107 | MP0008775_abnormal_heart_ventricle | 0.77626135 |
108 | MP0002136_abnormal_kidney_physiology | 0.77296544 |
109 | MP0005666_abnormal_adipose_tissue | 0.77203554 |
110 | MP0010630_abnormal_cardiac_muscle | 0.77011594 |
111 | MP0001485_abnormal_pinna_reflex | 0.76612459 |
112 | MP0005084_abnormal_gallbladder_morpholo | 0.76489526 |
113 | MP0008961_abnormal_basal_metabolism | 0.76473414 |
114 | MP0004085_abnormal_heartbeat | 0.74958799 |
115 | MP0001756_abnormal_urination | 0.74890303 |
116 | MP0009384_cardiac_valve_regurgitation | 0.73935863 |
117 | MP0005023_abnormal_wound_healing | 0.73618118 |
118 | MP0002060_abnormal_skin_morphology | 0.73400360 |
119 | MP0005058_abnormal_lysosome_morphology | 0.73205143 |
120 | MP0004272_abnormal_basement_membrane | 0.72372183 |
121 | MP0000762_abnormal_tongue_morphology | 0.72165234 |
122 | MP0004947_skin_inflammation | 0.70506945 |
123 | MP0000470_abnormal_stomach_morphology | 0.69069336 |
124 | MP0002133_abnormal_respiratory_system | 0.68733194 |
125 | MP0005388_respiratory_system_phenotype | 0.68733194 |
126 | MP0005319_abnormal_enzyme/_coenzyme | 0.68710300 |
127 | MP0005165_increased_susceptibility_to | 0.66718812 |
128 | MP0009931_abnormal_skin_appearance | 0.65125262 |
129 | MP0003638_abnormal_response/metabolism_ | 0.62951119 |
130 | MP0000013_abnormal_adipose_tissue | 0.62735684 |
131 | MP0000609_abnormal_liver_physiology | 0.60565906 |
132 | MP0000490_abnormal_crypts_of | 0.59708039 |
133 | MP0004145_abnormal_muscle_electrophysio | 0.59211877 |
134 | MP0005448_abnormal_energy_balance | 0.57722202 |
135 | MP0000681_abnormal_thyroid_gland | 0.56204063 |
136 | MP0002089_abnormal_postnatal_growth/wei | 0.55190881 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Right ventricular cardiomyopathy (HP:0011663) | 7.09671026 |
2 | Ileus (HP:0002595) | 4.94296232 |
3 | Hyperactive renin-angiotensin system (HP:0000841) | 4.91595456 |
4 | Ventricular tachycardia (HP:0004756) | 4.16775138 |
5 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.98156124 |
6 | Interstitial pulmonary disease (HP:0006530) | 3.95749340 |
7 | Syncope (HP:0001279) | 3.94540899 |
8 | Bundle branch block (HP:0011710) | 3.72372955 |
9 | Sudden death (HP:0001699) | 3.69533397 |
10 | Ventricular fibrillation (HP:0001663) | 3.67616870 |
11 | Chronic bronchitis (HP:0004469) | 3.62422539 |
12 | Onycholysis (HP:0001806) | 3.46313568 |
13 | Milia (HP:0001056) | 3.42301995 |
14 | Malnutrition (HP:0004395) | 3.32871194 |
15 | Hemorrhage of the eye (HP:0011885) | 3.32667891 |
16 | Palpitations (HP:0001962) | 3.25449219 |
17 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.22099995 |
18 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.22099995 |
19 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.18252125 |
20 | Distal lower limb amyotrophy (HP:0008944) | 3.17687035 |
21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.13929841 |
22 | Nasal polyposis (HP:0100582) | 3.13471098 |
23 | Rhinitis (HP:0012384) | 3.07851958 |
24 | Polycythemia (HP:0001901) | 3.06972217 |
25 | Abnormal ciliary motility (HP:0012262) | 3.06776482 |
26 | Hyporeflexia of lower limbs (HP:0002600) | 3.04164782 |
27 | Fragile nails (HP:0001808) | 3.03925882 |
28 | Pili torti (HP:0003777) | 3.03428547 |
29 | Abnormality of chloride homeostasis (HP:0011422) | 3.00152951 |
30 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.98155329 |
31 | Absent/shortened dynein arms (HP:0200106) | 2.98155329 |
32 | Abnormality of the nasal mucosa (HP:0000433) | 2.97355403 |
33 | Prolonged QT interval (HP:0001657) | 2.90256380 |
34 | Ventricular arrhythmia (HP:0004308) | 2.88806215 |
35 | Myopathic facies (HP:0002058) | 2.85110929 |
36 | Abnormal hair laboratory examination (HP:0003328) | 2.84450913 |
37 | Plantar hyperkeratosis (HP:0007556) | 2.77985126 |
38 | Flat acetabular roof (HP:0003180) | 2.73895599 |
39 | Gout (HP:0001997) | 2.73345517 |
40 | Woolly hair (HP:0002224) | 2.69138310 |
41 | Atrophic scars (HP:0001075) | 2.68206467 |
42 | Exercise-induced myalgia (HP:0003738) | 2.67062335 |
43 | Abnormality of renin-angiotensin system (HP:0000847) | 2.63738583 |
44 | Abdominal distention (HP:0003270) | 2.61466513 |
45 | Distal upper limb amyotrophy (HP:0007149) | 2.60605411 |
46 | Upper limb amyotrophy (HP:0009129) | 2.60605411 |
47 | Bronchiectasis (HP:0002110) | 2.59471188 |
48 | Hydroxyprolinuria (HP:0003080) | 2.59333910 |
49 | Abnormality of proline metabolism (HP:0010907) | 2.59333910 |
50 | Heart block (HP:0012722) | 2.57187814 |
51 | Increased connective tissue (HP:0009025) | 2.54604540 |
52 | Potter facies (HP:0002009) | 2.54175824 |
53 | Facial shape deformation (HP:0011334) | 2.54175824 |
54 | Dehydration (HP:0001944) | 2.53898505 |
55 | Hyperaldosteronism (HP:0000859) | 2.51776661 |
56 | Abnormal atrioventricular conduction (HP:0005150) | 2.49417059 |
57 | Myoglobinuria (HP:0002913) | 2.46630407 |
58 | Rectal prolapse (HP:0002035) | 2.43836133 |
59 | Stridor (HP:0010307) | 2.41901266 |
60 | Muscle fiber splitting (HP:0003555) | 2.40419112 |
61 | Abnormality of the gastric mucosa (HP:0004295) | 2.38848700 |
62 | Hyperkalemia (HP:0002153) | 2.37980674 |
63 | Hyperphosphatemia (HP:0002905) | 2.36489006 |
64 | Widely patent fontanelles and sutures (HP:0004492) | 2.32040692 |
65 | Conjugated hyperbilirubinemia (HP:0002908) | 2.31366167 |
66 | Decreased circulating renin level (HP:0003351) | 2.30885943 |
67 | Esophageal varix (HP:0002040) | 2.30866638 |
68 | Thin bony cortex (HP:0002753) | 2.30111788 |
69 | Hypobetalipoproteinemia (HP:0003563) | 2.28788489 |
70 | Atrial fibrillation (HP:0005110) | 2.28053855 |
71 | Visceral angiomatosis (HP:0100761) | 2.26225080 |
72 | Hyperparathyroidism (HP:0000843) | 2.24335662 |
73 | Alopecia of scalp (HP:0002293) | 2.22897929 |
74 | Exercise-induced muscle cramps (HP:0003710) | 2.21798855 |
75 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.21503879 |
76 | Obstructive sleep apnea (HP:0002870) | 2.20654093 |
77 | Systemic lupus erythematosus (HP:0002725) | 2.20635906 |
78 | Intrahepatic cholestasis (HP:0001406) | 2.20473102 |
79 | Tachypnea (HP:0002789) | 2.18704647 |
80 | Curly hair (HP:0002212) | 2.15643347 |
81 | Fat malabsorption (HP:0002630) | 2.14271181 |
82 | Hyponatremia (HP:0002902) | 2.14227975 |
83 | Alkalosis (HP:0001948) | 2.12981330 |
84 | Broad metatarsal (HP:0001783) | 2.12114477 |
85 | Cupped ribs (HP:0000887) | 2.10901595 |
86 | Acanthocytosis (HP:0001927) | 2.10076394 |
87 | Primary atrial arrhythmia (HP:0001692) | 2.09943662 |
88 | Bronchomalacia (HP:0002780) | 2.07213923 |
89 | Broad face (HP:0000283) | 2.06678743 |
90 | Bulbar palsy (HP:0001283) | 2.06377788 |
91 | Muscle fiber inclusion bodies (HP:0100299) | 2.05477530 |
92 | Hyperglycinuria (HP:0003108) | 2.04050723 |
93 | Difficulty running (HP:0009046) | 2.03525138 |
94 | Goiter (HP:0000853) | 2.02690366 |
95 | Abnormality of the 1st metacarpal (HP:0010009) | 2.02649122 |
96 | Hemangiomatosis (HP:0007461) | 2.02190260 |
97 | Abnormality of purine metabolism (HP:0004352) | 2.01906187 |
98 | Respiratory distress (HP:0002098) | 2.01688506 |
99 | Growth hormone excess (HP:0000845) | 2.00306702 |
100 | Acanthosis nigricans (HP:0000956) | 2.00258633 |
101 | Lipoatrophy (HP:0100578) | 1.98763665 |
102 | Ankle clonus (HP:0011448) | 1.98105868 |
103 | Complement deficiency (HP:0004431) | 1.98085821 |
104 | Renal salt wasting (HP:0000127) | 1.97640147 |
105 | Abnormality of complement system (HP:0005339) | 1.97369164 |
106 | J-shaped sella turcica (HP:0002680) | 1.97187592 |
107 | Metabolic alkalosis (HP:0200114) | 1.96547934 |
108 | Lower limb amyotrophy (HP:0007210) | 1.96361653 |
109 | Atelectasis (HP:0100750) | 1.94976132 |
110 | Supraventricular tachycardia (HP:0004755) | 1.94135094 |
111 | Type 1 muscle fiber predominance (HP:0003803) | 1.93033910 |
112 | Dilated cardiomyopathy (HP:0001644) | 1.92813560 |
113 | Supraventricular arrhythmia (HP:0005115) | 1.92753365 |
114 | Hypoplasia of dental enamel (HP:0006297) | 1.92674964 |
115 | Neck muscle weakness (HP:0000467) | 1.92641061 |
116 | Abnormal EKG (HP:0003115) | 1.92539459 |
117 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 1.92478032 |
118 | Axonal loss (HP:0003447) | 1.92361123 |
119 | Fragile skin (HP:0001030) | 1.92116724 |
120 | Popliteal pterygium (HP:0009756) | 1.92026933 |
121 | Germ cell neoplasia (HP:0100728) | 1.91551534 |
122 | Calf muscle hypertrophy (HP:0008981) | 1.91351303 |
123 | Round ear (HP:0100830) | 1.90553941 |
124 | Pigmentary retinal degeneration (HP:0001146) | 1.90356465 |
125 | Xanthomatosis (HP:0000991) | 1.90289439 |
126 | Easy fatigability (HP:0003388) | 1.90269497 |
127 | Nemaline bodies (HP:0003798) | 1.90160270 |
128 | Ketoacidosis (HP:0001993) | 1.89416557 |
129 | Abnormality of potassium homeostasis (HP:0011042) | 1.89365992 |
130 | Abnormality of vitamin metabolism (HP:0100508) | 1.87296403 |
131 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.86557632 |
132 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 1.86310200 |
133 | Hypotension (HP:0002615) | 1.85726712 |
134 | * Mildly elevated creatine phosphokinase (HP:0008180) | 1.85294801 |
135 | Gastrointestinal dysmotility (HP:0002579) | 1.83900063 |
136 | Atrioventricular block (HP:0001678) | 1.83387651 |
137 | Advanced eruption of teeth (HP:0006288) | 1.82982300 |
138 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.82727813 |
139 | Hyperuricemia (HP:0002149) | 1.82257970 |
140 | Increased purine levels (HP:0004368) | 1.82257970 |
141 | Hypolipoproteinemia (HP:0010981) | 1.81149367 |
142 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.80140548 |
143 | Congenital sensorineural hearing impairment (HP:0008527) | 1.79791272 |
144 | Hypoglycemic coma (HP:0001325) | 1.79515752 |
145 | Late onset (HP:0003584) | 1.79455181 |
146 | Adrenal overactivity (HP:0002717) | 1.78543641 |
147 | Palmoplantar keratoderma (HP:0000982) | 1.76467534 |
148 | Vascular calcification (HP:0004934) | 1.76019611 |
149 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.75457173 |
150 | EMG: myopathic abnormalities (HP:0003458) | 1.75152795 |
151 | Palmoplantar hyperkeratosis (HP:0000972) | 1.74902990 |
152 | Sudden cardiac death (HP:0001645) | 1.74525611 |
153 | Focal segmental glomerulosclerosis (HP:0000097) | 1.74433582 |
154 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.73212071 |
155 | Villous atrophy (HP:0011473) | 1.73212071 |
156 | Glomerulosclerosis (HP:0000096) | 1.72613733 |
157 | Distal lower limb muscle weakness (HP:0009053) | 1.72319268 |
158 | Abnormality of the calf musculature (HP:0001430) | 1.71599331 |
Rank | Gene Set | Z-score |
---|---|---|
1 | LMTK2 | 4.82530872 |
2 | RIPK1 | 3.65495501 |
3 | MST4 | 2.95524608 |
4 | FRK | 2.92258780 |
5 | MST1R | 2.92189364 |
6 | EPHA2 | 2.63383755 |
7 | PIK3CA | 2.21546255 |
8 | EPHB2 | 2.16150911 |
9 | MYLK | 2.05589568 |
10 | SMG1 | 2.03743159 |
11 | MAP3K2 | 2.02567455 |
12 | MAP2K2 | 2.00662035 |
13 | PRKG2 | 2.00295281 |
14 | EPHB1 | 1.96617707 |
15 | PTK6 | 1.92530527 |
16 | TTN | 1.89626913 |
17 | EEF2K | 1.84753058 |
18 | TRIB3 | 1.84089119 |
19 | FER | 1.77996190 |
20 | IRAK3 | 1.76979943 |
21 | DMPK | 1.75549926 |
22 | TIE1 | 1.70922565 |
23 | DDR2 | 1.68008260 |
24 | ERN1 | 1.64690917 |
25 | NME1 | 1.55920428 |
26 | KSR2 | 1.41349664 |
27 | PHKG1 | 1.41010190 |
28 | PHKG2 | 1.41010190 |
29 | TAOK1 | 1.38046892 |
30 | MAP3K7 | 1.25142046 |
31 | MUSK | 1.23922511 |
32 | RPS6KB2 | 1.23699548 |
33 | MET | 1.20376063 |
34 | PTK2 | 1.18435144 |
35 | TAOK3 | 1.16568405 |
36 | LATS1 | 1.12280038 |
37 | PAK4 | 1.11350205 |
38 | PDGFRA | 1.11329758 |
39 | SIK1 | 1.06915516 |
40 | MAP3K9 | 1.06867081 |
41 | PKN2 | 1.06834547 |
42 | MAP3K1 | 1.04482440 |
43 | ACVR1B | 1.04259705 |
44 | ICK | 1.03328623 |
45 | LRRK2 | 1.02469967 |
46 | MATK | 0.99176617 |
47 | STK24 | 0.98337864 |
48 | MAP3K3 | 0.98058063 |
49 | WNK4 | 0.96961416 |
50 | FGFR4 | 0.95412006 |
51 | ERBB2 | 0.93992284 |
52 | PAK3 | 0.91112780 |
53 | TESK1 | 0.87811550 |
54 | GRK6 | 0.86582037 |
55 | MAP2K1 | 0.86516094 |
56 | FGFR2 | 0.85006560 |
57 | PDPK1 | 0.83808035 |
58 | PRKD1 | 0.81079865 |
59 | CDC42BPA | 0.78881575 |
60 | CAMK2D | 0.77706746 |
61 | NEK6 | 0.77257817 |
62 | OBSCN | 0.76896936 |
63 | PDK4 | 0.76595896 |
64 | PDK3 | 0.76595896 |
65 | AKT3 | 0.75560921 |
66 | PRPF4B | 0.75467686 |
67 | PRKAA2 | 0.68290525 |
68 | ROCK1 | 0.68193594 |
69 | DAPK2 | 0.68140098 |
70 | TGFBR2 | 0.68080701 |
71 | BMX | 0.68054463 |
72 | FGFR3 | 0.67462350 |
73 | STK10 | 0.67026214 |
74 | MAP3K10 | 0.66537740 |
75 | PDGFRB | 0.66157772 |
76 | MTOR | 0.66137525 |
77 | MAPK15 | 0.65952895 |
78 | MAP2K6 | 0.64169962 |
79 | MARK2 | 0.64097338 |
80 | TYRO3 | 0.64007774 |
81 | MAPK11 | 0.63101876 |
82 | OXSR1 | 0.62701740 |
83 | PRKCI | 0.62687716 |
84 | EPHA3 | 0.61927650 |
85 | IRAK2 | 0.59751094 |
86 | STK39 | 0.59382132 |
87 | TRPM7 | 0.58126154 |
88 | RPS6KA2 | 0.57413887 |
89 | CAMK2B | 0.57270158 |
90 | WNK1 | 0.56067865 |
91 | PRKAA1 | 0.55787836 |
92 | INSRR | 0.55288511 |
93 | PDK2 | 0.54762183 |
94 | SGK3 | 0.54736935 |
95 | NEK1 | 0.53709448 |
96 | PRKD2 | 0.53567232 |
97 | MAPKAPK3 | 0.53528011 |
98 | STK38 | 0.49805534 |
99 | NTRK1 | 0.49353928 |
100 | MAP3K11 | 0.47991843 |
101 | RET | 0.47900212 |
102 | CDK12 | 0.47225047 |
103 | PRKD3 | 0.47076239 |
104 | ROCK2 | 0.46999971 |
105 | IRAK1 | 0.46800745 |
106 | DYRK1B | 0.45800160 |
107 | CAMK2G | 0.45715973 |
108 | TBK1 | 0.45246765 |
109 | PINK1 | 0.44950536 |
110 | STK38L | 0.44439974 |
111 | SCYL2 | 0.43451559 |
112 | MAP3K6 | 0.43019307 |
113 | DAPK3 | 0.41813262 |
114 | CHUK | 0.41280999 |
115 | PDK1 | 0.40020771 |
116 | GSK3A | 0.39700571 |
117 | GRK1 | 0.39552087 |
118 | ILK | 0.38012575 |
119 | HIPK2 | 0.36421144 |
120 | CSK | 0.36169011 |
121 | SRC | 0.35657989 |
122 | MAP2K3 | 0.35342191 |
123 | LIMK1 | 0.34648317 |
124 | LATS2 | 0.34361501 |
125 | BCKDK | 0.34208434 |
126 | MAP3K8 | 0.33573104 |
127 | EPHA4 | 0.30394337 |
128 | MAPKAPK2 | 0.26933350 |
129 | AKT2 | 0.25424870 |
130 | RPS6KL1 | 0.23231376 |
131 | RPS6KC1 | 0.23231376 |
132 | MAPK12 | 0.22223307 |
133 | MAP3K12 | 0.21660278 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.24793071 |
2 | Mineral absorption_Homo sapiens_hsa04978 | 3.05731179 |
3 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.88144428 |
4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.66185993 |
5 | Bile secretion_Homo sapiens_hsa04976 | 2.26960310 |
6 | Renin-angiotensin system_Homo sapiens_hsa04614 | 2.13133661 |
7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.04258400 |
8 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.03238340 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.86642818 |
10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.86531612 |
11 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.70876565 |
12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.69755943 |
13 | Galactose metabolism_Homo sapiens_hsa00052 | 1.61875706 |
14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.59889902 |
15 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.59302404 |
16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.57941304 |
17 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.56076217 |
18 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.54606584 |
19 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.53578625 |
20 | Histidine metabolism_Homo sapiens_hsa00340 | 1.52651586 |
21 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.49549637 |
22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.44858084 |
23 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.43474567 |
24 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.30161511 |
25 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.28897584 |
26 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.26954744 |
27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.23341240 |
28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.23280351 |
29 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.19809920 |
30 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.19340964 |
31 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.19077403 |
32 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.18411912 |
33 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.17507084 |
34 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.16773315 |
35 | * Tight junction_Homo sapiens_hsa04530 | 1.15677237 |
36 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.12474193 |
37 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.04539433 |
38 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.03951094 |
39 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.03936978 |
40 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.03581728 |
41 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.00335257 |
42 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00058443 |
43 | Salivary secretion_Homo sapiens_hsa04970 | 0.98478188 |
44 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96808344 |
45 | ABC transporters_Homo sapiens_hsa02010 | 0.93148187 |
46 | Adherens junction_Homo sapiens_hsa04520 | 0.92397326 |
47 | Carbon metabolism_Homo sapiens_hsa01200 | 0.91150093 |
48 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91148488 |
49 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.89010136 |
50 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.88657418 |
51 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.88141097 |
52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.87852880 |
53 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.87050709 |
54 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.86949105 |
55 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.86678332 |
56 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.86268060 |
57 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.86068001 |
58 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.85647723 |
59 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.82663090 |
60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.80079235 |
61 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79599843 |
62 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77950035 |
63 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74610380 |
64 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.73696255 |
65 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72832234 |
66 | Other glycan degradation_Homo sapiens_hsa00511 | 0.72026932 |
67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.71335102 |
68 | Renin secretion_Homo sapiens_hsa04924 | 0.70655800 |
69 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68910003 |
70 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.68088890 |
71 | Bladder cancer_Homo sapiens_hsa05219 | 0.68040101 |
72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67346399 |
73 | Insulin secretion_Homo sapiens_hsa04911 | 0.64025561 |
74 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.62498415 |
75 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.62333365 |
76 | Insulin resistance_Homo sapiens_hsa04931 | 0.60369972 |
77 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.59209664 |
78 | Hepatitis C_Homo sapiens_hsa05160 | 0.58995516 |
79 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.58256622 |
80 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.56949610 |
81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.54469609 |
82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.53679105 |
83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.52360452 |
84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51887817 |
85 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.51563063 |
86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.51545018 |
87 | Amoebiasis_Homo sapiens_hsa05146 | 0.50180666 |
88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.49968296 |
89 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.49120648 |
90 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47653434 |
91 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.45538990 |
92 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45453840 |
93 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45360800 |
94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.44695035 |
95 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44442385 |
96 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.44049159 |
97 | Thyroid cancer_Homo sapiens_hsa05216 | 0.42981695 |
98 | Focal adhesion_Homo sapiens_hsa04510 | 0.42802986 |
99 | Peroxisome_Homo sapiens_hsa04146 | 0.42593624 |
100 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.42591935 |
101 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.42548387 |
102 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.42503185 |
103 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.41412783 |
104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.40203247 |
105 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.38213030 |
106 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.36062316 |
107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35154849 |
108 | Gap junction_Homo sapiens_hsa04540 | 0.35126172 |
109 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35091910 |
110 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.34945593 |
111 | Taste transduction_Homo sapiens_hsa04742 | 0.34689872 |
112 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.33794526 |
113 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33055977 |
114 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.32872572 |
115 | Lysine degradation_Homo sapiens_hsa00310 | 0.32650594 |
116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.32411687 |
117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.31469672 |
118 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.30958142 |
119 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28910541 |
120 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28311890 |
121 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.27618758 |
122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.27404294 |
123 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27392958 |